<DOC>
	<DOCNO>NCT00824694</DOCNO>
	<brief_summary>To show structured treatment plan base upon Accu-Chek 360 View favorable effect physician decision-making HbA1c patient oral hypoglycemic agent ( OHA ) insulin type 2 diabetes ( T2D ) . Hypothesis 1 : Compared control , intervention subject undergo great number medication change low HbA1 conclusion study . Hypothesis 2 : Higher rate monitor entry associate low CHO consumption , low percent body fat , high medication compliance , high physical activity level . Hypothesis 3 : Patients low rate monitor entry high rate depression , likely external locus control , express great fear self-testing .</brief_summary>
	<brief_title>Impact Accu-Chek 360 Veterans With Type 2 Diabetes</brief_title>
	<detailed_description>Primary care provider ( PCP 's ) randomize intervention control arm . Their T2D patient identify search computerized pharmacy record OHA insulin , follow stable medical regimen , eligible participate baseline HbA1c 7.0 - 9.5 % OHA 7.5 - 10.0 % insulin . Two sample frame create intervention patient : one patient OHA alone one patient insulin alone combination OHA . The procedure use develop corresponding sample frame control patient . OHA patient randomly sample intervention control group ratio 1:1 174 subject enrol . Insulin patient recruit manner another 174 subject recruit . At entry , patient measurement fat mass , insulin-resistance , stimulate C-peptide , carbohydrate intake , physical activity level . The intervention consist target SMBG , provider training , patient education , focus normalizing significant glucose abnormality give time . SMBG alternate 2 strategy : glucose profile target monitoring . Intervention PCP 's use 360 View identify patient 's significant glucose elevation ( ) devise treatment plan include medication use , start dose , dose increment per cycle , interval dose increase , monitor time frequency , goal target , stop criterion . Separate treatment protocol recommend OHA patient basal hyperglycemia , OHA patient PP hyperglycemia , insulin patient basal hyperglycemia , insulin patient PP hyperglycemia . Treatment conform current standard practice define package insert Micromedex , VA 's official on-line drug reference . Subjects repeat dose titration cycle guidance case manager target reach , maximal recommend dos medication use , stop criterion meet . They resume glucose profile identify next target . This process repeat target reach optimal value . Intervention subject undergo less 4 cycle 48 week . Control patient monitor treated customary manner .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Must primary care provider Diabetes diagnose age 35 Eat 3 meal daily ≤ 1 snack If OHA , willingness start insulin Type 1 diabetes DKA On insulin pump CGM Preference language English Ca n't wo n't monitor Unfavorable occupation live arrangement Terminal illness Active alcoholism substance abuse Severe depression Chronic liver disease Pituitary adrenal dysfunction Immunosuppression Hct &lt; 35 Creatinine ≥ 2.5</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Glucose</keyword>
	<keyword>Diabetes Mellitus , Type 2</keyword>
	<keyword>HbA1c</keyword>
</DOC>